Live feed07:30:00·23dPRReleasevia QuantisnowImmunityBio Reports Net Product Revenue Increased Nearly 2.7 Times Year-Over-Year to Record $44 Million in Q1 2026 and $381 Million in Cash and Marketable SecuritiesByQuantisnow·Wall Street's wire, on your screen.IBRX· ImmunityBio Inc.Health Care
